Navigation Links
AEterna Zentaris Announces Changes to its Management Team
Date:4/11/2008

QUEBEC CITY, April 11 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (Nasdaq: AEZS TSX: AEZ;), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that David J. Mazzo, Ph.D., has resigned as President and Chief Executive Officer and as member of the Board of Directors of AEterna Zentaris, effective immediately. Mr. Juergen Ernst, the current Chairman of the Board of AEterna Zentaris, has been appointed as the interim President and Chief Executive Officer of the Company and will serve in that capacity until a suitable replacement is identified and appointed by the Board of Directors. Ellen McDonald, MBA, the Senior Vice President, Business Operations and Chief Business Officer of AEterna Zentaris, has also resigned from the Company effective immediately.

Management and the Board of Directors of AEterna Zentaris wish to thank Dr. Mazzo and Ms. McDonald for their significant efforts on behalf of the Company and to recognize Dr. Mazzo's contribution to the Board of Directors.

Mr. Ernst, Chairman of the Board and Interim President and CEO of AEterna Zentaris, commented: "We have confidence in the experienced management team in place and will further advance our products through the pipeline, continuing to focus and prioritize on our Phase 3 program with cetrorelix in benign prostatic hyperplasia (BPH) and our Phase 2 program with AEZS-108 for endometrial and ovarian cancer. We believe that we have a solid foundation and a robust development pipeline, and we will continue to develop its full potential."

Mr. Ernst added: "We will continue to monetize our non-core assets in order to provide additional sources of non-dilutive funding." In that regard, AEterna Zentaris completed the sale of Echelon Biosciences in December 2007 for US$3.2 million and the sale in March 2008 of all rights relating to the use of miltefosine for Cdn$9.125 million.

Furthermore, the Board of Directors has authorized managem
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Boston, Mass. (PRWEB) July 10, 2014 ... , today announced that Alan Swahn, a former vice ... Terascala’s executive team as vice president of marketing. Terascala’s ... from Dell and NetApp create the highest performance and ... has been appointed to guide Terascala’s channel expansion and ...
(Date:7/10/2014)... OMICS Group’s 5th International conference and exhibition ... at Double Tree by Hilton Beijing, China is all ... & Bioanalytical research methods only to facilitate improved living ... Dr. Srinubabu Gedela, MD of OMICS Group Inc has ... one in bringing a unique and international mix of ...
(Date:7/10/2014)... , July 10, 2014  Franciscan ... use of capnography for respiratory monitoring outside ... of healthcare leaders in embracing state-of-the-art patient ... effectively patients are breathing and can alert ... By measuring the amount of carbon dioxide ...
(Date:7/10/2014)... 2014 /PRNewswire-iReach/ -- Tute Genomics, the leader ... an agreement with Lineagen, Inc., to provide ... Dx PLUS.  Lineagen, focused on the ... currently offers FirstStep Dx PLUS, a ... by healthcare providers as a first-line genetic ...
Breaking Biology Technology:Terascala Expands Executive Team 2Terascala Expands Executive Team 3A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4
... measure the ability to tune out negativity, author and ... southeastern Wisconsin technology professionals. , ,Kawasaki, managing partner of ... of the Start" and several other business books, gave ... eInnovate. He poked some good-natured fun at politicians, Microsoft ...
... Standard Networks, Inc., a Madison software developer, achieved ... months of 2006, thanks largely to a 125 percent ... message transfer management products. , ,Citing its privately held ... MOVEit, but said Standard Network's overall revenues increased by ...
... Wis. - In a move to comply with ... Security, an Internet security provider, as a partner in ... union clients. , ,The move comes as financial institutions ... comply with Federal Financial Institutions Examination Council requirements to ...
Cached Biology Technology:Beating back the bozos is an innovation must, says Kawasaki 2
(Date:7/14/2014)... in 2005, controls T-cell activation and differentiation by ... so, it helps to guarantee immunological tolerance and ... that can lead to autoimmune disease. Roquin is ... five and ten per cent of the population. ... environmental influences when a genetic predisposition exists. Only ...
(Date:7/14/2014)... than 140 years ago, Charles Darwin noticed something peculiar ... species are more tame, and they also tend to ... ears, patches of white fur, and more juvenile faces ... this pattern has proved elusive, but now, in a ... a new hypothesis has been proposed that could explain ...
(Date:7/13/2014)... women suggests that experiencing one or more stressful events ... slow the body,s metabolism, potentially contributing to weight gain. ... stressors before giving them a meal consisting of 930 ... measured their metabolic rate how long it took ... took measures of blood sugar, triglycerides, insulin and the ...
Breaking Biology News(10 mins):Molecular mechanisms underlying the prevention of autoim-munity by Roquin revealed 2Domestication syndrome: White patches, baby faces and tameness 2Weighty issue: Stress and high-fat meals combine to slow metabolism in women 2Weighty issue: Stress and high-fat meals combine to slow metabolism in women 3Weighty issue: Stress and high-fat meals combine to slow metabolism in women 4
... at WEHI into a possible new cancer drug suggests ... less toxic than current chemotherapeutic drugs. , Dr David ... teams from WEHI's cancer research divisions have been assessing ... developed by US-based healthcare company, Abbott. , ...
... around the world keep a nervous eye on the spread ... Disease Organization (VIDO) has uncovered a key step in how ... team have discovered how a crucial pathway that supports the ... finding that could pave the way for new drugs and ...
... get lab results back from the doctor's office soon could ... of University of Georgia researchers has developed a diagnostic test ... RSV in 60 seconds or less. , In addition to ... issue of the journal Nano Letters ?could save lives by ...
Cached Biology News:Hope for a more effective and less toxic cancer drug 2U of S Vaccine and Infectious Disease Organization team discovers key step in flu virus replication 2Silver bullet: UGA researchers use laser, nanotechnology to rapidly detect viruses 2Silver bullet: UGA researchers use laser, nanotechnology to rapidly detect viruses 3
...
Cag-A (IgG) -Ab EIA Sample Size: 10 l...
... RNaseOUT Recombinant Ribonuclease Inhibitor is ... pancreatic-type ribonucleases such as RNase ... RNaseOUT Recombinant Ribonuclease Inhibitor is ... molecular weight ~52 kDa. RNaseOUT ...
... RNase Inhibitor (Ribonuclease inhibitor) is ... used to inhibit RNase activity. ... or endonuclease activity. , ... of RNA template , ...
Biology Products: